SUVONSTOBART
UNII 359SBX4N6E

Substance Identification & Data

This profile provides standardized clinical and technical data for Suvonstobart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 359SBX4N6E.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2983834-87-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

359SBX4N6E

CAS Registry Number

2983834-87-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SUVONSTOBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C215772

National Cancer Institute reference terminology for clinical and research data.

INN ID

13347

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

Suvonstobart

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Suvonstobart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

Suvonstobart

Common Names & Synonyms

Immunoglobulin G1 [298-alanine,333-alanine,334-alanine], anti-(human CD24 antigen) (human-Mus musculus monoclonal IMM47 γ1-chain), disulfide with human-Mus musculus monoclonal IMM47 κ-chain, dimer

immunoglobulin G1-kappa, anti-[Homo sapiens CD24 (signal transducer CD24)], monoclonal antibody; H-gamma1 heavy chain (1-447) [VH Musmus/Homsap (Mus musculus IGHV3-1*02 (98.0%) -(IGHD) -IGHJ4*01 (87.5%) G121>R (110)/Homo sapiens IGHV4-30-4*09 (74.5%) -(IGHD) -IGHJ4*01 (78.6%) G121>R (110), L123>S (112), CDR-IMGT [9.7.10] (26-34.52-58.97-106)) (1-117) -Homo sapiens IGHG1*03,G1m3, nG1m1 CH1 R120, CH3 E12, M14, 2-G1v6 CH2 A85.4, A118, A119 (CH1 R120 (214) (118-215), hinge 1-15 (216-230), CH2 S85.4>A (298), E118>A (333), K119>A (334) (231-340), CH3 E12 (356), M14 (358) (341-445), CHS (446-447)) (118-447)], (220-220')-disulfide with L-kappa light chain (1'-220') [V-KAPPA (Homo sapiens IGKV1-27*01 (82.3%) -IGKJ4*01 (91.7%) I126>L (112'), CDR-IMGT [12.3.9] (27'-38'.56'-58'.95'-103')) (1'-113') -Homo sapiens IGKC*01 (100%) Km3 A45.1, V101 (C-KAPPA A45.1 (159'), V101 (197')) (114'-220')]; dimer (226-226'':229-229'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, cell line CHO-K1, glycoform alfa

suvonstobart [INN]